ES2031453T3 - Gene-clonas del virus de la enfermedad de newcastle. - Google Patents
Gene-clonas del virus de la enfermedad de newcastle.Info
- Publication number
- ES2031453T3 ES2031453T3 ES198686309804T ES86309804T ES2031453T3 ES 2031453 T3 ES2031453 T3 ES 2031453T3 ES 198686309804 T ES198686309804 T ES 198686309804T ES 86309804 T ES86309804 T ES 86309804T ES 2031453 T3 ES2031453 T3 ES 2031453T3
- Authority
- ES
- Spain
- Prior art keywords
- newcastle disease
- disease virus
- clones
- virus gene
- genes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000711404 Avian avulavirus 1 Species 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 208000010359 Newcastle Disease Diseases 0.000 abstract 1
- 108010067390 Viral Proteins Proteins 0.000 abstract 1
- 238000010367 cloning Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
EL PROBLEMA DE PROPORCIONAR UN ACCESO RAPIDO A UN POLINUCLEOTIDO CON CODIFICACION DE LA PROTEINA HN Y/O F DEL ARN DEL VIRUS DE LA ENFERMEDAD DE NEWCASTLE SE RESUELVE, DE ACUERDO CON LA INVENCION, RECOMBINANDO LA TECNOLOGIA ADN QUE HA CONDUCIDO A LA CLONACION Y SECUENCIA DE ESTOS GENES. LA INVENCION PROPORCIONA DICHOS POLINUCLEOTIDOS Y, EN PARTICULAR, AQUELLOS DE LA CEPA VIRAL BEAUDETTE C Y OTROS SUFICIENTEMENTE HOMOLOGOS CON ESTO PARA PERMITIR QUE LOS GENES HN Y F DE OTRAS CEPAS SEAN IDENTIFICADOS USANDO BEAUDETTE C DNA COMO MUESTRA. LA INVENCION ES UTIL EN LA DIAGNOSIS DE LA ENFERMEDAD DE NEWCASTLE Y COMO ETAPA PRINCIPAL HACIA LA PRODUCCION DE PROTEINAS VIRICAS PARA USO EN VACUNACION DE AVES.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858531147A GB8531147D0 (en) | 1985-12-18 | 1985-12-18 | Disease virus gene clones |
GB868609037A GB8609037D0 (en) | 1986-04-14 | 1986-04-14 | Newcastle disease virus gene clones |
US88576586A | 1986-07-15 | 1986-07-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2031453T3 true ES2031453T3 (es) | 1992-12-16 |
Family
ID=27262863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES198686309804T Expired - Lifetime ES2031453T3 (es) | 1985-12-18 | 1986-12-16 | Gene-clonas del virus de la enfermedad de newcastle. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5310678A (es) |
EP (1) | EP0227414B1 (es) |
JP (1) | JP2534246B2 (es) |
AU (1) | AU602875B2 (es) |
CA (1) | CA1319337C (es) |
DE (1) | DE3679049D1 (es) |
ES (1) | ES2031453T3 (es) |
NZ (1) | NZ218630A (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
US7767449B1 (en) | 1981-12-24 | 2010-08-03 | Health Research Incorporated | Methods using modified vaccinia virus |
US5174993A (en) * | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
ZA874677B (en) * | 1986-06-30 | 1988-11-30 | Smith Kline Rit | Dna sequence,recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides,obtained products and preparations containing same |
JP2531729B2 (ja) * | 1987-03-27 | 1996-09-04 | 日本ゼオン株式会社 | 組み換えアビポックスウイルス |
EP0284416B1 (en) * | 1987-03-27 | 1995-02-22 | Nippon Zeon Co., Ltd. | Recombinant avipoxyvirus |
DE10399032I1 (de) * | 1987-08-28 | 2004-01-29 | Health Research Inc | Rekombinante Viren. |
US5286639A (en) * | 1987-09-16 | 1994-02-15 | Nippon Zeon Co., Ltd. | Recombinant avipoxvirus |
CA1340203C (en) * | 1987-09-16 | 1998-12-15 | Noboru Yanagida | Recombinant apivoxvirus |
GB8724885D0 (en) * | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
FR2632863B2 (fr) * | 1987-10-29 | 1990-08-31 | Transgene Sa | Virus du fowlpox recombinant et vaccins derives de ces virus |
FR2622456B1 (fr) * | 1987-10-29 | 1990-02-02 | Transgene Sa | Virus du fowlpox recombinant, vecteurs d'expression de proteines heterologues et vaccins pour la volaille derives de ce virus |
JP2781605B2 (ja) * | 1989-06-22 | 1998-07-30 | 日本ゼオン株式会社 | 組み換えアビポックスウイルス |
CA2158461A1 (en) * | 1993-03-16 | 1994-09-29 | Christian Ertel | Stimulation of immune response by viral protein |
ATE236271T1 (de) * | 1993-04-30 | 2003-04-15 | Wellstat Biologics Corp | Verwendung der ndv zur herstellung eines medikaments zur krebsbehandlung |
US5871744A (en) * | 1996-09-05 | 1999-02-16 | University Of Maryland-Biotechnology Inst. | Method for generating birnavirus from synthetic RNA transcripts |
US6231868B1 (en) | 1997-09-30 | 2001-05-15 | University Of Maryland-Biotechnology Institute | Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts |
EP0974660A1 (en) * | 1998-06-19 | 2000-01-26 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Newcastle disease virus infectious clones, vaccines and diagnostic assays |
AU4606000A (en) * | 1999-06-10 | 2001-01-02 | Agricultural Research Council | Vaccine for newcastle disease virus |
KR100454870B1 (ko) * | 2001-07-30 | 2004-11-03 | 주식회사 인트론바이오테크놀로지 | 뉴캐슬병 바이러스의 f 단백질과 hn 단백질 및 그의유전자들 |
KR100437888B1 (ko) * | 2001-07-30 | 2004-07-03 | 주식회사 인트론바이오테크놀로지 | 뉴캐슬병 바이러스 검출용 프라이머 및 상기 프라이머를이용한 뉴캐슬병 바이러스 검출, 병원성 및 유전형 조사방법 |
US8394944B2 (en) * | 2002-09-20 | 2013-03-12 | Siemens Healthcare Diagnostics Inc. | Dual-purpose primers and probes for providing enhanced hybridization assays by disruption of secondary structure formation |
KR20060029214A (ko) * | 2003-05-05 | 2006-04-05 | 다우 아그로사이언시즈 엘엘씨 | 이식 유전자 식물 세포들로부터 유래된 안정한 면역예방적및 치료적 조성물들 및 생산방법 |
CN1293195C (zh) * | 2005-09-02 | 2007-01-03 | 中国农业科学院哈尔滨兽医研究所 | 新城疫LaSota疫苗株反向遗传操作系统及其应用 |
AU2006312126A1 (en) * | 2005-11-04 | 2007-05-18 | Dow Agrosciences Llc | Preparation of vaccine master cell lines using recombinant plant suspension cultures |
KR100776398B1 (ko) | 2006-03-23 | 2007-11-28 | 주식회사 고려비엔피 | 조류 hn 단백질의 에피토프 및 상기 변이 에피토프를포함하는 뉴캐슬병 바이러스 |
KR100955502B1 (ko) | 2007-11-30 | 2010-04-30 | 대한민국 | 병원성 뉴캐슬병 바이러스 항체와 특이적으로 반응하는펩타이드 및 그의 용도 |
TR201818883T4 (tr) | 2011-10-21 | 2019-01-21 | Intervet Int Bv | Enfeksiyöz laringotrakeit virüsü ve Newcastle hastalığı virüsü antijenlerini kodlayan rekombinant patojenik olmayan marek hastalığı virüsü yapıları. |
RU2593950C2 (ru) | 2011-10-21 | 2016-08-10 | Интервет Интернэшнл Б.В. | Рекомбинантный непатогенный mdv-вектор, обеспечивающий полиспецифический иммунитет |
CN104513317B (zh) * | 2013-09-30 | 2018-12-14 | 普莱柯生物工程股份有限公司 | 一种疫苗组合物及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3429965A (en) * | 1966-08-01 | 1969-02-25 | Sterling Drug Inc | Avian pox virus vaccine and process of preparing same |
US4603112A (en) * | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
US4743553A (en) * | 1984-07-18 | 1988-05-10 | W. R. Grace & Co. | Synthetic genes for bovine parainfluenza virus |
ZA874677B (en) * | 1986-06-30 | 1988-11-30 | Smith Kline Rit | Dna sequence,recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides,obtained products and preparations containing same |
-
1986
- 1986-12-11 AU AU66441/86A patent/AU602875B2/en not_active Expired
- 1986-12-15 NZ NZ218630A patent/NZ218630A/xx unknown
- 1986-12-16 EP EP86309804A patent/EP0227414B1/en not_active Expired
- 1986-12-16 DE DE8686309804T patent/DE3679049D1/de not_active Expired - Lifetime
- 1986-12-16 ES ES198686309804T patent/ES2031453T3/es not_active Expired - Lifetime
- 1986-12-17 CA CA000525534A patent/CA1319337C/en not_active Expired - Lifetime
- 1986-12-18 JP JP61302719A patent/JP2534246B2/ja not_active Expired - Lifetime
-
1989
- 1989-11-17 US US07/438,945 patent/US5310678A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA1319337C (en) | 1993-06-22 |
AU6644186A (en) | 1987-06-25 |
US5310678A (en) | 1994-05-10 |
JP2534246B2 (ja) | 1996-09-11 |
AU602875B2 (en) | 1990-11-01 |
DE3679049D1 (de) | 1991-06-06 |
EP0227414A3 (en) | 1988-05-04 |
NZ218630A (en) | 1988-08-30 |
EP0227414A2 (en) | 1987-07-01 |
EP0227414B1 (en) | 1991-05-02 |
JPS62163693A (ja) | 1987-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2031453T3 (es) | Gene-clonas del virus de la enfermedad de newcastle. | |
Chan et al. | Chloroplast DNA codes for the primary structure of the large subunit of fraction I protein | |
ATE451462T1 (de) | Klonierung und expression von htlv-iii-dns | |
ES487106A0 (es) | Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv | |
DE3686304D1 (de) | Typenspezifische papillomavirus-dns-sequenzen und peptide. | |
ES2119776T3 (es) | Proteina d- una proteina que une igd de haemophilus influenzae. | |
ES2147553T3 (es) | Vectores virales recombinantes para la expresion en unas celulas musculares. | |
PT84427B (pt) | Processo para a producao de interferoes hibridos uteis como agentes terapeuticos e como intermediarios para a producao de anticorpos bem como de composicoes farmaceuticas que os contem | |
DE3587840D1 (de) | Für das Polypeptid des T-Zellantigenreceptors kodierende Nukleinsäure. | |
MX9202815A (es) | Codificacion del polideoxirribonucleotido, plasmida y procedimiento para preparar un clono que contiene plasmida. | |
ES2062993T3 (es) | Factor de crecimiento humano i semejante a la preproinsulina. | |
ES2144399T3 (es) | Clonado del adn de virus de anemia de los pollos. | |
AR016436A1 (es) | Proteina que inhibe a la p27, adn que la codifica, anticuerpos y productos de disociacion de los mismos, acido nucleico antisentido, estructura artificialde acido nucleico y la utilizacion de todo esto en terapia y profilaxis de enfermedades | |
AR247245A1 (es) | Una molecula adn para insertar en una cepa bacteriana gram-negativa que contiene un gen insertado constituido por promotor del complejo nitrogenasa de rhizobium y gen estructural | |
ES2058486T3 (es) | Inmunogenos nativos y recombinantes del grupo b de eimeria tenella utiles como vacunas para las coccidiosis. | |
ATE130631T1 (de) | Verfahren zur isolierung für thymidin-kinase der herpesvirus kodierenden dns. | |
ES509946A0 (es) | Un metodo para aumentar la produccion de proteinas por adn heterologo, en vectores de clonacion de plasmidos. | |
ES2090357T3 (es) | Una proteina de union a colageno asi como su preparacion. | |
ES2074422T3 (es) | Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso. | |
Koteliansky et al. | The effect of non-muscle tropomyosin on the interaction of filamin with F-actin | |
ES546597A0 (es) | Un procedimiento para preparar un microorganismo hospedante transformado del genero sacharomyces. | |
CO5280143A1 (es) | Mutantes de ehv gm-negativa | |
ES2045004T3 (es) | Procedimiento para la preparacion de proteinas extra\as en estreptomicetos. | |
ES2107997T3 (es) | Procedimiento de uso de vectores de expresion eucarioticos que comprenden el potenciador del virus bk. | |
ES2037795T3 (es) | Procedimiento para la preparacion del antigeno hrpii de plasmodium falciparum sge2. |